Performa Ltd (US)’s CVS Health CVS Stock Holding History

Performa Ltd (US)’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-400	Closed	-$18K	–	55
2024 Q4	$18K	Buy	+400	New	+$22.4K	0.01%	25

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Performa Ltd (US)'s CVS Position: Q1 2025 in Review

Performa Ltd (US) sold out of CVS Health (CVS) in Q1 2025, closing a stake of 400 shares — an estimated $18K sold.

Performa Ltd (US) first reported a position in CVS in Q4 2024 and held it in 1 quarter. The position peaked at $18K in Q4 2024. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

Performa Ltd (US) reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
Performa Ltd (US) sold 400 CVS Health shares in Q1 2025, an estimated $18K.
Performa Ltd (US) first reported a position in CVS Health in Q4 2024 and held it in 1 quarter.
Performa Ltd (US)'s CVS Health position peaked at $18K in Q4 2024.
1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Performa Ltd (US)'s 13F filing for Q1 2025, filed 9 May 2025.